Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Institute for Medical Engineering and Science and Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Science. 2023 Jul 14;381(6654):164-170. doi: 10.1126/science.adh1114. Epub 2023 Jul 13.
Despite advances in molecular biology, genetics, computation, and medicinal chemistry, infectious disease remains an ominous threat to public health. Addressing the challenges posed by pathogen outbreaks, pandemics, and antimicrobial resistance will require concerted interdisciplinary efforts. In conjunction with systems and synthetic biology, artificial intelligence (AI) is now leading to rapid progress, expanding anti-infective drug discovery, enhancing our understanding of infection biology, and accelerating the development of diagnostics. In this Review, we discuss approaches for detecting, treating, and understanding infectious diseases, underscoring the progress supported by AI in each case. We suggest future applications of AI and how it might be harnessed to help control infectious disease outbreaks and pandemics.
尽管分子生物学、遗传学、计算科学和药物化学取得了进展,但传染病仍然是公共卫生的一个严重威胁。应对病原体爆发、大流行和抗微生物药物耐药性带来的挑战,需要协调多学科的努力。人工智能(AI)与系统和合成生物学结合,正在带来快速进展,扩大抗感染药物的发现,增进我们对感染生物学的理解,并加速诊断方法的发展。在这篇综述中,我们讨论了用于检测、治疗和理解传染病的方法,强调了 AI 在每种情况下所支持的进展。我们提出了 AI 的未来应用,以及如何利用它来帮助控制传染病的爆发和大流行。